Rusia y AstraZeneca se unen en nuevos ensayos clínicos para derrotar al COVID-19
infobae,
“Anunciamos un programa de ensayos clínicos para evaluar la seguridad y la inmunogenecidad de la combinación de ASD1222…
“Anunciamos un programa de ensayos clínicos para evaluar la seguridad y la inmunogenecidad de la combinación de ASD1222…
WHO: Remdesivir Not Advised for Hospitalized COVID-19 Patients Acceptable safety profile identified, with three serious adverse…
Government reveals priority plan for coronavirus vaccine There are fears that poorer countries could be left behind as richer…
Pamela Baca has dedicated two years of her life to help researchers collect data during AstraZeneca's COVID-19 vaccine trial.
El laboratorio británico AstraZeneca y el instituto ruso Gamaleya anunciaron que harán pruebas de combinación de sus vacunas…
El laboratorio británico AstraZeneca y el instituto ruso Gamaleya anunciaron que harán pruebas de combinación de sus vacunas…
Full interim analysis of the safety and efficacy of the Oxford Covid-19 vaccine – developed in partnership with AstraZeneca …
News Professional FRIDAY, Dec. 11, 2020 -- The ChAdOx1 nCoV-19 vaccine has an overall efficacy of 70.4 percent, with an…
Les premiers résultats détaillés officiellement publiés d’un vaste essai clinique du vaccin contre le Covid-19 développé par l’un…
International— Lancement de la campagne de vaccination anti-Covid au Royaume-Uni, recrudescence de la pandémie…, nos équipes réda…
Full interim analysis of the safety and efficacy of the Oxford COVID-19 vaccine – developed in partnership with AstraZeneca …
The year 2020 will enter the history books as the year in which a new deadly coronavirus brought the world to a halt.
في السباق الحالي نحو تطعيم الناس لتفادي الإصابة بكوفيد-19، يبدو لقاح "فايزر/بايونتيك" متقدما على باقي اللقاحات.
La farmacéutica británica AstraZeneca ha anunciado este viernes que iniciará un ensayo clínico para probar su vacuna…
Full interim analysis of the safety and efficacy of the Oxford COVID-19 vaccine – developed in partnership with AstraZeneca …
Lancet. 2020 Dec 8:S0140-6736(20)32661-1. doi: 10.1016/S0140-6736(20)32661-1. Online ahead of print.
Lancet. 2020 Dec 8:S0140-6736(20)32661-1. doi: 10.1016/S0140-6736(20)32661-1. Online ahead of print.
Lancet. 2020 Dec 8:S0140-6736(20)32661-1. doi: 10.1016/S0140-6736(20)32661-1. Online ahead of print.
COVID-19 vaccine developer AstraZeneca has withdrawn its application to conduct Phase 3 clinical trials in the Philippines, the…
But early missteps leave some questioning findings Interim results showed the Oxford-AstraZeneca Covid-19 vaccine to have…
Full interim analysis of the safety and efficacy of the Oxford COVID-19 vaccine – developed in partnership with AstraZeneca …
After the first vaccines against Covid-19 demonstrated efficacy, public health officials began to foresee a gradual end to the…
(Bloomberg) -- After the first vaccines against Covid-19 demonstrated efficacy, public health officials began to foresee a…
Oxford y AstraZeneca habían adelantado a finales de noviembre que la tasa de efectividad de su candidata lograba el 90 por…
These are the global coronavirus stories you need to know about this week. The UK's rollout of the Pfizer/BioNTech vaccine…
Denne artikkelen er over en måned gammel, og kan inneholde utdaterte råd fra myndighetene angående koronasmitten.
In this special installment of our Hope Behind the Headlines series, we overview the latest advancements in vaccine development.
James Gallagher* – Reprter de Sade e Cincia da BBC Efeitos colaterais da vacina: o que se sabe sobre a segurana dos imunizantes…
Procédé de fabrication, efficacité, effets indésirables... Ce que l'on sait sur le vaccin développé par l'Université d'Oxford…
A vacina Pfizer/BioNTech reduz os casos de covid em cerca de 95% das pessoas imunizadas, mas acarreta efeitos colaterais…
A peer-reviewed journal has confirmed the 70 percent efficacy of the Oxford AstraZeneca coronavirus vaccine | Joel Saget AFP…
Em qualquer discussão sobre se uma vacina é segura, há um dado que vale a pena ter em mente: 1 em 850.
The reality of getting a coronavirus vaccine approaches. Pfizer’s vaccine is already administered in the United Kingdom, and…
Credit: Shutterstock The Oxford/AstraZeneca vaccine this week became the first major COVID vaccine candidate to have efficacy…
A study of the Oxford/AstraZeneca CCP virus vaccine trials published in the Lancet has raised questions around the vaccine’s…
Oxford-AstraZeneca vaccine safe and effective against COVID: Latest study confirms AstraZeneca and Oxford University have more…
编者按:本文来自微信公众号 “Nature自然科研”(ID:Nature-Research) ,作者:Nature自然科研,36氪经授权发布。 原文作者:Heidi Ledford 一种新冠肺炎疫苗的大型临床试验首次正式公布试验结果,表明该疫苗是安全有效的…
The Oxford/AstraZeneca vaccine this week became the first major COVID vaccine candidate to have efficacy results from phase 3…
The Oxford/AstraZeneca vaccine this week became the first major COVID vaccine candidate to have efficacy results from phase 3…
Vaccine is safe and effective, albeit maybe not as effective as the two other leading candidates Full interim analysis of the…
Vaccine is safe and effective, albeit maybe not as effective as the two other leading candidates Full interim analysis of the…
Vaccine is safe and effective, albeit maybe not as effective as the two other leading candidates Full interim analysis of the…
Vaccine is safe and effective, albeit maybe not as effective as the two other leading candidates Full interim analysis of the…
When you subscribe we will use the information you provide to send you these newsletters.
Vaccine is safe and effective, albeit maybe not as effective as the two other leading candidates Full interim analysis of the…
Ny studie viser få alvorlige bivirkninger av Oxford-vaksinen. - Lovende, mener immunolog.
South African study data were used to evaluate the safety of the vaccine in the results just published, but not its efficacy [whi…
Das Team hinter dem Impfstoffkandidaten Oxford/Astra Zeneca hat erstmals vollumfänglich Daten zu seinen Phase-3-Versuchen veröffe…
Update: AstraZeneca announced in November that its COVID-19 vaccine developed with the University of Oxford had an average…
Infectious Disease > COVID-19 Improved efficacy with botched dosing still unexplained The AstraZeneca/University of Oxford…
KOMPAS.com - Menurut penelitian peer-review yang terbit di jurnal The Lancet, vaksin Covid-19 yang dikembangkan Oxford-AstraZenec…
Update: AstraZeneca announced in November that its COVID-19 vaccine developed with the University of Oxford had an average…
2 hours ago · 8 min read Recently, I found myself saying designers should be thinking more like product managers but continue…
On Tuesday, regulators at the U.S. Food and Drug Administration, the regulatory body that approves new pharmaceuticals, had an…
مع اقتراب حصول لقاح AstraZeneca المنتظر ضد " كوفيد-19 " على موافقة المملكة المتحدة، تُظهر البيانات التي جرت مراجعتها من قبل النظر…
TEGUCIGALPA, HONDURAS.- Las noticias sobre las vacunas experimentales para prevenir el covid-19 no paran de llegar, entre ellas…
A vaccine from the University of Oxford and AstraZeneca shows only a limited ability to stop transmission of the coronavirus…
Researchers from AstraZeneca and Oxford University have published results from their SARS-CoV-2 clinical trial, but BuzzFeed…
– By Paul Hunter, Professor of Medicine, University of East Anglia Full interim analysis of the safety and efficacy of the…
Infectious Disease > COVID-19 This past week in healthcare investigations by Kristina Fiore, Director of Enterprise
In één dag verschenen er data over twee vaccinkandidaten tegen covid-19. In de Lancet beschrijven Merry Voysey en anderen…
Full interim analysis of the safety and efficacy of the Oxford COVID-19 vaccine – developed in partnership with AstraZeneca …
Los resultados publicados en la revista The Lancet convierten a la vacuna desarrollada por AstraZeneca y la Universidad Británica…
Si le candidat d’AstraZeneca est le premier vaccin « à publier » ses résultats d’essai de phase III, le vaccin de Pfizer vient…
AstraZeneca y la Universidad de Oxford dieron a conocer en un estudio científico revisado por pares y publicado en la revista méd…
Un vaccin validé par The Lancet. C'est l'un des trois projets les plus avancés.
CAPE TOWN - The latest COVID-19 vaccine proven to be safe and effective is best suited to be deployed in Africa.
For the first time, Covid-19 vaccine phase 3 human trial results have been peer-reviewed and published in a scientific journal.
The Guardian : Oxford/AstraZeneca Covid vaccine has 70% efficacy, full trial data shows “The Oxford/AstraZeneca Covid vaccine…
Pfizer CEO shares his expectations for its coronavirus disease 2019 (COVID-19) vaccine approval; peer review results are in for…
L'ESSENTIEL L'efficacité à 70% du vaccin contre la Covid-19 d'AstraZeneca est confirmée par la revue scientifique The Lancet…
Infectious Disease > COVID-19 A daily roundup of news on COVID-19 and the rest of medicine by Judy George, Senior Staff Writer…
A group of advisers to the Food and Drug Administration met Thursday to review an application from Pfizer and BioNTech for…
Une étude publiée dans "The Lancet" confirme un taux d'efficacité de 70,4% en moyenne du vaccin anti-Covid-19 développé par…
Los resultados publicados ayer en The Lancet respecto a la efectividad de la vacuna contra COVID-19 de la Universidad de Oxford…
Un vaccin validé par The Lancet. C'est l'un des trois projets les plus avancés.
First full results from interim analysis confirm that the Oxford COVID-19 vaccine (AZD1222) has an acceptable safety profile…
Covering COVID-19 is a daily Poynter briefing of story ideas about the coronavirus and other timely topics for journalists…
L’analisi ad interim pubblicata sulla rivista scientifica inglese indica che il vaccino ChAdOx1 nCoV-19 ha un buon profilo di…
© iStock-kovop58 The first full results from the Phase III Oxford COVID-19 vaccine have found it to be safe and effective to…
Full data from late-phase trials of AstraZeneca’s COVID-19 vaccine have pointed to the potential for AZD1222 to work after a…
Ehdollisella luvalla rokotteen pääsy markkinoille voisi nopeutua merkittävästi.
The coronavirus vaccine developed by the Oxford University and United Kingdom-based drugmaker AstraZeneca has 90% efficacy in a…
Forscher der Universität Oxford haben die klinische Prüfung ihres Covid-19-Impfstoffes nun in einer Fachzeitschrift publiziert.
Forscher der Universität Oxford haben die klinische Prüfung ihres Covid-19-Impfstoffes nun in einer Fachzeitschrift publiziert.
Erstmals Phase-III-Studiendaten Vor Kurzem hat Astra Zeneca viel diskutierte Zwischenergebnisse zum Impfstoff „AZD1222“ bekannt…
Covid-19 Alert The data raised questions about the most effective dosing regimen, and how well it worked for adults above the…
Zum ersten Mal sind Resultate zur Wirksamkeit eines Covid-19-Impfstoffs in einer begutachteten Fachzeitschrift veröffentlicht…
Home / World News / AstraZeneca vaccine better at stopping Covid-19 than slowing transmission: Report A vaccine from the…
Morocco's King Mohammed VI ordered that all Moroccans should receive a coronavirus vaccine for free, the Royal palace said on…